Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Nutrition ; 57: 32-39, 2019 01.
Artículo en Inglés | MEDLINE | ID: mdl-30153577

RESUMEN

OBJECTIVES: The aim of this study was to investigate the effects of two different sources of polyunsaturated fatty acid-fish oil (FO) and argan oil (AO)-on some risk factors for cardiovascular disease, such as platelet aggregation, dyslipidemia, and oxidative stress. METHODS: To explore this, four groups of six male rats were fed with different diets: The first group received a standard diet (control); the second group received a high-fat diet; the third was fed with a high-fat diet supplemented with 5% FO, and the last group received a high-fat diet supplemented with 5% AO. RESULTS: After 8 wk of the diet, AO showed a decrease in plasma lipids similar to that of FO. However, unlike FO, AO had no significant effect on hepatic lipid levels. On the other hand, supplementation with AO and FO similarly reduced platelet hyperactivity induced by high-fat diet. Concerning the results of oxidative stress, AO showed an antioxidant effect in the tissues and platelets greater than that observed in the high-fat FO group. CONCLUSIONS: For rats, the consumption of FO prevented the development of adiposity, restored insulin sensitivity, decreased plasma and liver lipid levels, and also prevented the prothrombotic effect. Intake of AO as a food supplement did not affect adiposity or liver lipid levels but decreased plasma lipid levels and improved oxidative status and platelet activity. FO and, to a lesser degree, AO thus represent promising nutritional tools in the prevention of cardiovascular disease.


Asunto(s)
Enfermedades Cardiovasculares/prevención & control , Dieta Alta en Grasa/efectos adversos , Suplementos Dietéticos , Aceites de Pescado/farmacología , Lípidos/sangre , Aceites de Plantas/farmacología , Adiposidad/efectos de los fármacos , Animales , Enfermedades Cardiovasculares/sangre , Enfermedades Cardiovasculares/etiología , Modelos Animales de Enfermedad , Aceites de Pescado/sangre , Masculino , Ratones , Ratas , Ratas Wistar , Factores de Riesgo
2.
Lipids ; 51(9): 1037-49, 2016 09.
Artículo en Inglés | MEDLINE | ID: mdl-27503614

RESUMEN

Dietary supplementation with marine omega-3 polyunsaturated fatty acids (n-3 PUFA) can have beneficial effects on a number of risk factors for cardiovascular disease (CVD). We compared the effects of two n-3 PUFA rich food supplements (freeze-dried Odontella aurita and fish oil) on risk factors for CVD. Male rats were randomly divided into four groups of six animals each and fed with the following diets: control group (C) received a standard diet containing 7 % lipids; second group (HF high fat) was fed with a high-fat diet containing 40 % lipids; third group (HFFO high fat+fish oil) was fed with the high-fat diet supplemented with 0.5 % fish oil; and fourth group (HFOA high fat+O. aurita) received the high-fat diet supplemented with 12 % of freeze-dried O. aurita. After 8 weeks rats fed with the high-fat diet supplemented with O. aurita displayed a significantly lower bodyweight than those in the other groups. Both the microalga and the fish oil significantly reduced insulinemia and serum lipid levels. O. aurita was more effective than the fish oil in reducing hepatic triacyglycerol levels and in preventing high-fat diet-induced steatosis. O. aurita and fish oil also reduced platelet aggregation and oxidative status induced by high fat intake. After an OA supplementation, the adipocytes in the HFOA group were smaller than those in the HF group. Freeze-dried O. aurita showed similar or even greater biological effects than the fish oil. This could be explained by a potential effect of the n-3 PUFA but also other bioactive compounds of the microalgae.


Asunto(s)
Enfermedades Cardiovasculares/prevención & control , Ácidos Grasos Omega-3/administración & dosificación , Hígado Graso/prevención & control , Aceites de Pescado/química , Microalgas/química , Animales , Peso Corporal/efectos de los fármacos , Dieta Alta en Grasa/efectos adversos , Suplementos Dietéticos , Modelos Animales de Enfermedad , Ácidos Grasos Omega-3/farmacología , Hígado Graso/inducido químicamente , Lípidos/sangre , Masculino , Estrés Oxidativo/efectos de los fármacos , Distribución Aleatoria , Ratas , Resultado del Tratamiento
3.
J Endocrinol ; 228(1): 1-12, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26459640

RESUMEN

The beneficial effect of polyunsaturated omega-3 fatty acid (w-3 FA) consumption regarding cardiovascular diseases, insulin resistance and inflammation has been widely reported. Fish oil is considered as the main source of commercialized w-3 FAs, and other alternative sources have been reported such as linseed or microalgae. However, despite numerous reports, the underlying mechanisms of action of w-3 FAs on insulin resistance are still not clearly established, especially those from microalgae. Here, we report that Odontella aurita, a microalga rich in w-3 FAs eicosapentaenoic acid, prevents high fat diet-induced insulin resistance and inflammation in the liver of Wistar rats. Indeed, a high fat diet (HFD) increased plasma insulin levels associated with the impairment of insulin receptor signaling and the up-regulation of toll-like receptor 4 (TLR4) expressions. Importantly, Odontella aurita-enriched HFD (HFOA) reduces body weight and plasma insulin levels and maintains normal insulin receptor expression and responsiveness. Furthermore, HFOA decreased TLR4 expression, JNK/p38 phosphorylation and pro-inflammatory factors. In conclusion, we demonstrate for the first time, to our knowledge, that diet supplementation with whole Ondontella aurita overcomes HFD-induced insulin resistance through the inhibition of TLR4/JNK/p38 MAP kinase signaling pathways.


Asunto(s)
Dieta Alta en Grasa/efectos adversos , Dieta , Ácidos Grasos Omega-3/administración & dosificación , Resistencia a la Insulina , Hepatopatías/prevención & control , Microalgas , Adiposidad , Animales , Peso Corporal , Suplementos Dietéticos , Ácido Eicosapentaenoico/administración & dosificación , Hepatitis/prevención & control , Insulina/sangre , Lípidos/sangre , Hígado/metabolismo , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Masculino , Fosforilación , Ratas , Ratas Wistar , Transducción de Señal/efectos de los fármacos , Receptor Toll-Like 4/antagonistas & inhibidores
4.
Lipids Health Dis ; 12: 107, 2013 Jul 20.
Artículo en Inglés | MEDLINE | ID: mdl-23870174

RESUMEN

BACKGROUND: It is now established that patients with hyperlipidemia have a high risk of atherosclerosis and thrombotic complications, which are two important events responsible for the onset and progression of cardiovascular disease. In the context of managing dyslipidemia by means of dietary advice based on the consumption of argan oil, we wanted to investigate the effect of virgin argan oil on plasma lipids, and for the first time, on the platelet hyperactivation and oxidative status associated with dyslipidemia. This study concerns patients recruited in the area of Rabat in Morocco. METHODS: 39 dyslipidemic (79% women) patients were recruited for our study in the area of Rabat in Morocco. They were randomly assigned to the two following groups: the argan group, in which the subjects consumed 25 mL/day of argan oil at breakfast for 3 weeks, and the control group in which argan oil was replaced by butter. RESULTS: After a 3-week consumption period, blood total cholesterol was significantly lower in the argan oil group, as was LDL cholesterol (23.8% and 25.6% lower, respectively). However, the HDL cholesterol level had increased by 26% at the end of the intervention period compared to baseline. Interestingly, in the argan oil group thrombin-induced platelet aggregation was lower, and oxidative status was enhanced as a result of lower platelet MDA and higher GPx activity, respectively. CONCLUSIONS: In conclusion, our results, even if it is not representative of the Moroccan population, show that argan oil can prevent the prothrombotic complications associated with dyslipidemia, which are a major risk factor for cardiovascular disease.


Asunto(s)
Dislipidemias/sangre , Dislipidemias/tratamiento farmacológico , Lípidos/sangre , Estrés Oxidativo/efectos de los fármacos , Aceites de Plantas/administración & dosificación , Adulto , Aterosclerosis/complicaciones , Aterosclerosis/tratamiento farmacológico , Aterosclerosis/patología , Colesterol/sangre , HDL-Colesterol/sangre , LDL-Colesterol/sangre , Dislipidemias/complicaciones , Dislipidemias/patología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Marruecos , Agregación Plaquetaria/efectos de los fármacos , Sapotaceae/química , Trombosis/complicaciones , Trombosis/tratamiento farmacológico , Trombosis/patología
5.
Int J Environ Health Res ; 17(4): 243-57, 2007 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-17613089

RESUMEN

The objective of the study was to investigate whether air quality in western Morocco is truly a significant risk factor in the development and exacerbation of respiratory diseases and, in particular, asthma. The continuous measurement of the mean concentrations of sulfur dioxide (SO(2)) in the air and the density of Total Suspended Particulates (TSP) for a period of four years was determined. Information on individual characteristics and indoor environments from 1318 children with an average age of 12 years was evaluated by questionnaire, completed by parents (assisted by professional investigators) and symptoms/diseases were medically diagnosed and reported. We have used the Student's t-test, Chi-square tests & odds ratios (ORs) with 95% confidence intervals (CI 95%) for estimates of the risk of asthma. The prevalence of asthma varies in a significant way according to the zone (chi(2) = 14.61, p < 0.05). Respiratory diseases (OR 6.27, 95% confidence interval [CI] 4.09-9.64, p < 0.0001), strongly polluted zone (OR 3.62, 95% CI 1.71-7.81, p < or = 0.0001) and infectious diseases (OR 3.29, 95% CI 1.99-5.47, p < 0.0001) are high risk factors for asthma. Air pollution is a determinant factor but is not the only factor increasing the risk of asthma in children; other factors such as respiratory diseases, infectious diseases, genetic and passive smoking present a high-risk threat.


Asunto(s)
Contaminación del Aire , Asma/epidemiología , Dióxido de Azufre/análisis , Adolescente , Niño , Monitoreo del Ambiente , Monitoreo Epidemiológico , Humanos , Marruecos , Prevalencia , Factores de Riesgo , Dióxido de Azufre/toxicidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA